Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Withdrawn 1Suspended 1Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 111Neoplasm Metastasis 9Neoplasms 5Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms, Male 3Breast Diseases 3Obesity 2Multiple Endocrine Neoplasia Type 1 2Endometrial Neoplasms 2Breast Cancer Metastatic 2Arthralgia 2Triple Negative Breast Neoplasms 1Thoracic Neoplasms 1Sleep Wake Disorders 1Skin Diseases 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Prostatic Neoplasms 1Primary Breast Cancer ER+ve 1Post Menopausal Women With Early Breast Cancer 1Patient Acceptance of Health Care 1Pain 1Ovarian Neoplasms 1Neoplasms by Site 1Metastatic Beast Cancer 1Mammary Neoplasms, Animal 1Lymphoma 1Lung Neoplasms 1Lung Diseases 1Lethal Congenital Contracture Syndrome 2 1

Interventions

Tamoxifen 10Chemotherapy, Adjuvant 7Radiotherapy 5Early Intervention, Educational 5Psychiatric Rehabilitation 4Neoadjuvant Therapy 4Letrozole 4Counseling 4Behavior Therapy 4Anastrozole 4Methods 3Mass Spectrometry 3Magnetic Resonance Spectroscopy 3Immunohistochemistry 3Gene Expression Profiling 3Biopsy 3Telemedicine 2Taxes 2Soybean Proteins 2Simvastatin 2Paclitaxel 2Medroxyprogesterone 2Fatty Acids, Omega-3 2Educational Status 2Docosahexaenoic Acids 2Curcumin 2Chromatography, High Pressure Liquid 2Brachytherapy 2telapristone acetate 1ruxolitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Breast Carcinoma In Situ × exemestane × Clear all
NCT02598557 2023-08-22

Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer

National Cancer Institute (NCI)

Phase 2 Completed
180 enrolled 46 charts
Breast

Breast Carcinoma In Situ, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡